Status:
COMPLETED
Antagonist Protocol in Poor Responders
Lead Sponsor:
Cairo University
Conditions:
Female Infertility Due to Diminished Ovarian Reserve
Eligibility:
FEMALE
20-45 years
Phase:
PHASE4
Brief Summary
The effect of use of the growth hormone with antagonist protocol on the outcome of the IVF/ICSI cycles in poor responders.
Detailed Description
Two groups of poor responder female patients planned to receive the antagonist IVF/ICSI protocol are randomized to whether or not to add growth hormone to their protocol.
Eligibility Criteria
Inclusion
- females fulfilling the criteria of the ESHRE consensus 2011:
- at least two of the following three features must be present:
- dvanced maternal age (≥40 years) or any other risk factor for POR
- previous POR (≤3 oocytes with a conventional stimulation protocol)
- an abnormal ovarian reserve test (i.e. AFC ,5-7 follicles or AMH ,0.5 -1.1 ng/ml).
Exclusion
- women who suffer from any other cause of infertility other than poor ovarian reserve
- refusal of the patient to consent for using her data in the study.
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT02195947
Start Date
July 1 2014
End Date
July 1 2015
Last Update
November 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Al Aini
Cairo, Egypt